February 2025
1. PENG X, Lian Z, O'Brien V, Xiao J, et al
   Foamy monocytes and atherogenesis in mice with combined hyperlipidemia and effects of antisense knockdown of apoCIII.
   J Lipid Res. 2025 Feb 21:100763. doi: 10.1016/j.jlr.2025.100763.
   

   >> Share

   
   January 2025
2. WESTBYE AB, Dizdarevic LL, Dahl SR, Asprusten EA, et al
   A sterol panel for rare lipid disorders: sitosterolemia, cerebrotendinous xanthomatosis and Smith-Lemli-Opitz syndrome.
   J Lipid Res. 2025;66:100698.
   

   >> Share

   
   November 2024
3. DUDDU S, Katakia YT, Chakrabarti R, Sharma P, et al
   New Epigenome Players in the Regulation of PCSK9 - H3K4me3 and H3K9ac Alteration by Statins in hypercholesterolemia.
   J Lipid Res. 2024 Nov 18:100699. doi: 10.1016/j.jlr.2024.100699.
   

   >> Share

   
   
4. LA CHICA LHOEST MT, Martinez A, Garcia E, Dandurand J, et al
   ApoB100 Remodeling and Stiffened Cholesteryl Ester Core Raise LDL Aggregation in Familial Hypercholesterolemia Patients.
   J Lipid Res. 2024 Nov 16:100703. doi: 10.1016/j.jlr.2024.100703.
   

   >> Share

   
   August 2024
5. JIN Y, Kozan D, Young ED, Hensley M, et al
   A high-cholesterol zebrafish diet promotes hypercholesterolemia and fasting-associated liver steatosis.
   J Lipid Res. 2024 Aug 30:100637. doi: 10.1016/j.jlr.2024.100637.
   

   >> Share

   
   July 2024
6. BARDEY F, Rieck L, Spira D, Marz W, et al
   Clinical characterization and mutation spectrum of patients with hypertriglyceridemia in a German outpatient clinic.
   J Lipid Res. 2024 Jul 3:100589. doi: 10.1016/j.jlr.2024.100589.
   

   >> Share

   
   
7. LI C, Tian J, Liu N, Song D, et al
   MicroRNA-206 as a potential cholesterol-lowering drug is superior to statins in mice.
   J Lipid Res. 2024;65:100576.
   

   >> Share

   
   June 2024
8. YANG Y, Konrad RJ, Ploug M, Young SG, et al
   APOA5 Deficiency Causes Hypertriglyceridemia by Reducing Amounts of Lipoprotein Lipase in Capillaries.
   J Lipid Res. 2024 Jun 14:100578. doi: 10.1016/j.jlr.2024.100578.
   

   >> Share

   
   
9. JIANG L, Gangireddy S, Dickson AL, Xin Y, et al
   Characterizing genetic profiles for high triglyceride levels in U.S. patients of African ancestry.
   J Lipid Res. 2024;65:100569.
   

   >> Share

   
   February 2024
10. CHACKERIAN B, Remaley AT
    PCSK9 Vaccines: A promising new strategy for the treatment of hypercholesterolemia?
    J Lipid Res. 2024 Feb 17:100524. doi: 10.1016/j.jlr.2024.100524.
    

    >> Share

    
    
11. VROOM MM, Lu H, Lewis M, Thibodeaux BA, et al
    VXX-401, a novel anti-PCSK9 vaccine, reduces LDL-C in cynomolgus monkeys.
    J Lipid Res. 2024;65:100497.
    

    >> Share

    
    January 2024
12. SLIJKHUIS N, Razzi F, Korteland SA, Heijs B, et al
    Spatial Lipidomics of Coronary Atherosclerotic Plaque Development in a Familial Hypercholesterolemia Swine Model.
    J Lipid Res. 2024 Jan 19:100504. doi: 10.1016/j.jlr.2024.100504.
    

    >> Share

    
    December 2023
13. CHAPMAN MJ, Orsoni A, Mellett NA, Nguyen A, et al
    Statin treatment remodels the HDL subclass lipidome and proteome in hypertriglyceridemia.
    J Lipid Res. 2023 Dec 29:100494. doi: 10.1016/j.jlr.2023.100494.
    

    >> Share

    
    
14. MEDEIROS AM, Alves AC, Miranda B, Chora JR, et al
    Unravelling the genetic background of individuals with a clinical Familial Hypercholesterolemia phenotype.
    J Lipid Res. 2023 Dec 18:100490. doi: 10.1016/j.jlr.2023.100490.
    

    >> Share

    
    
15. JAMES JK, Norland K, Johar AS, Kullo IJ, et al
    Deep generative models of LDLR protein structure to predict variant pathogenicity.
    J Lipid Res. 2023;64:100455.
    

    >> Share

    
    July 2023
16. WANG Y, Kong L, Ye C, Dou C, et al
    Hypertriglyceridemic hyperapoB and the development and resolution of nonalcoholic fatty liver disease: A cohort study.
    J Lipid Res. 2023 Jul 20:100418. doi: 10.1016/j.jlr.2023.100418.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share